arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CONMED Corp

CNMD
$52.79 ▼ -0.90 (-1.68%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
18 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
61
Health
Fair
Neutral
auto_awesome

Analytical Summary

CONMED Corp shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.6B
Dividend Yield 1.14%
Revenue Growth 5.2% ↗
Op. Margin 7.5% ↘
ROIC 6.6% ↘
FCF / Share $4.86 ↘
Trailing P/E 34.7x
Price / Book 1.6x
FCF Yield 9.2%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.37B
↑ +5.2% —
Net Income Profit after all expenses
$47.05M
↓ -64.5% —
Operating Margin Operating profit as % of sales
7.5%
↓ -51.3% 50th
FCF / Share Free cash flow per share
$4.86
↓ -2.6% —
Long-Term Debt Long-term obligations
$456.90M
↓ -6.1% —

Health Breakdown

Profitability ↓
53
Returns ↓
53
Financial Health ↑
67
Cash Quality ↑
92

Dividend History

Dividend / share · sourced from SEC filings
$0.60 Latest / share
-25.0% YoY
-2.6% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 69 quarters